Short answer
CME Group (CME) filed its Q3 2025 10-Q quarterly report on Oct 24, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1.5B (down 3.0% year over year) with net income of $897M.
Q3 2025 key financials · XBRL
- Revenue
- $1.5B
- −3.0% YoY · −9.1% QoQ
- Net income
- $897M
- −0.5% YoY · −11.4% QoQ
- Operating margin
- 63.3%
- EPS (diluted)
- $2.49
- −0.4% YoY · −11.4% QoQ
Source: XBRL data from the CME Group (CME) Q3 2025 10-Q on SEC EDGAR. USD.
CME Group Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,537.6M Q3 2025, down 3% YoY from $1,584.4M Q3 2024
- Operating margin 63.3% Q3 2025 vs 64.6% YoY, net income $908.0M vs $912.8M, EPS $2.49 stable YoY
- Clearing and transaction fees down 5% to $1,227.9M, market data revenue up to $202.5M (+14% YoY)
- Cash flow from operations increased to $3,143.2M for 9 months ended Sept 2025, up from $2,672.6M
- Management notes lower Q3 volumes due to reduced market volatility, maintains strong liquidity and ongoing $3B stock repurchase authorization
Risk Factors
- No material changes in risk factors from 2024 10-K disclosed in this 10-Q
- Market volatility risk remains significant due to changing economic conditions affecting trading volumes
- Regulatory compliance risk persists with ongoing SEC and CFTC oversight and evolving derivatives regulations
- Operational risk from technology disruptions could impact platform availability and trading execution
- Financial risk from interest rate fluctuations affecting funding costs and investment portfolio valuation
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CME Group quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.